Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study.


PURPOSE Gastrointestinal stromal tumor (GIST) has been considered radiation-resistant, and radiotherapy is recommended only for palliation of bone metastases in current treatment guidelines. No registered prospective trial has evaluated GIST responsiveness to radiotherapy. PATIENTS AND METHODS Patients with GIST progressing at intra-abdominal sites or the… (More)
DOI: 10.1016/j.radonc.2015.07.025


4 Figures and Tables